Geneia Awarded NCQA Accreditation for its Care Management Programs
August 16, 2016
Harrisburg, PA – Geneia, an analytics and technology leader in transforming healthcare delivery , has received full, three-year National Committee on Quality Assurance (NCQA) Case Management Accreditation and Patient and Practitioner Oriented Disease Management Accreditation for its asthma, coronary artery disease, heart failure, chronic obstructive pulmonary disease and diabetes programs. Geneia joins a select group of healthcare organizations whose level of commitment to patient-centered, quality healthcare has been recognized by the nation’s most prestigious accrediting body. As of August 16, only 32 organizations are accredited for standalone complex case management and 17 have achieved this distinction for standalone disease management services.
"NCQA's Disease Management Accreditation program is thorough and rigorous. It's designed to highlight only those programs that truly improve chronic care," said NCQA President Margaret E. O'Kane. “Case Management Accreditation moves us closer to measuring quality across population health management initiatives. Not only does it add value to existing quality improvement efforts; it also demonstrates an organization’s commitment to the highest degree of improving the quality of their patients’ care.”
Mark A. Caron CHCIO, FACHE, CEO of Geneia, commented, "Customers applaud Geneia for its robust combination of clinical services and analytics solutions that help them improve the health status of their patients and workforce. NCQA recognition is further confirmation of the high caliber of our patient-centered case and disease management programs.”
Geneia Chief Medical Officer Jennifer Chambers, MD, MBA, FACP, said, “In addition to recognizing the clinical rigor of Geneia’s programs for the sickest patients, NCQA accreditation is proof positive of our commitment to provider and patient satisfaction – and we know satisfaction contributes significantly to better health outcomes.”
Caron added, “Effective care management programs for patients with chronic conditions such as heart disease and diabetes are central to efforts to achieve the Triple Aim, and in particular, mitigate healthcare costs. A recent American Health Policy Institute (AHPI) study found ‘high-cost claimants,’ those employees whose healthcare costs exceeds $50,000 per year, represent a disproportionate 31 percent of total health spending. The study also determined that 52.6 percent of high-cost claims are for chronic conditions, most of which can benefit from the kind of disease and case management programs offered by Geneia.”
NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Web site ( www.ncqa.com) contains information to help consumers, employers and others make more informed healthcare choices.
Geneia LLC is a healthcare analytics and services company. We work to improve collaboration between healthcare providers, health plans and employers to better support personalized, patient-centered care. Through advanced technology, education and training, insights and clinical services, we help clients better identify and actively manage high-risk populations, improve quality measurement and outcomes, and strengthen revenue. Rooted in deep clinical experience and leading-edge data science, our client-centric, phased approach to population health simplifies the transition to risk and value-based care. Our offices are located in Harrisburg, PA and Manchester, NH. To learn more, visit Geneia.com (https://www.geneia.com) or connect with us on Facebook, Twitter and LinkedIn.